Literature DB >> 26210630

Hyperinsulinemic Hypoglycemia.

Maria Güemes1, Khalid Hussain2.   

Abstract

In hyperinsulinemic hypoglycemia (HH) there is dysregulation of insulin secretion from pancreatic β-cells. Insulin secretion becomes inappropriate for the level of blood glucose leading to severe hypoglycemia. HH is associated with a high risk of brain injury because insulin inhibits lipolysis and ketogenesis thus preventing the generation of alternative brain substrates (such as ketone bodies). Hence HH must be diagnosed as soon as possible and the management instituted appropriately to prevent brain damage. This article reviews the mechanisms of glucose physiology in the newborn, the mechanisms of insulin secretion, the etiologic types of HH, and its management.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  18F-l-dihydroxyphenylalanine positron emission tomographic scan; Diazoxide; Hyperinsulinism; Hypoglycemia; Mammalian target of rapamycin (mTOR) inhibitor; Octreotide; Pancreatectomy

Mesh:

Substances:

Year:  2015        PMID: 26210630     DOI: 10.1016/j.pcl.2015.04.010

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  11 in total

Review 1.  Therapeutic RNA-silencing oligonucleotides in metabolic diseases.

Authors:  Algera Goga; Markus Stoffel
Journal:  Nat Rev Drug Discov       Date:  2022-02-24       Impact factor: 84.694

2.  Transient neonatal hyperinsulinaemic hypoglycaemia: perinatal predictors of length and cost of stay.

Authors:  Kazune Kozen; Theodore Dassios; Nick Kametas; Ritika R Kapoor; Anne Greenough
Journal:  Eur J Pediatr       Date:  2018-09-19       Impact factor: 3.183

3.  Anxiety, depression, and quality of life in parents of children with congenital hyperinsulinism.

Authors:  Marcia Roeper; Henrike Hoermann; Roschan Salimi Dafsari; Felix Koestner; Ertan Mayatepek; Sebastian Kummer; Christina Reinauer; Thomas Meissner
Journal:  Eur J Pediatr       Date:  2022-05-04       Impact factor: 3.860

4.  Clinical practice guidelines for congenital hyperinsulinism.

Authors:  Tohru Yorifuji; Reiko Horikawa; Tomonobu Hasegawa; Masanori Adachi; Shun Soneda; Masanori Minagawa; Shinobu Ida; Takeo Yonekura; Yoshiaki Kinoshita; Yutaka Kanamori; Hiroaki Kitagawa; Masato Shinkai; Hideyuki Sasaki; Masaki Nio
Journal:  Clin Pediatr Endocrinol       Date:  2017-07-27

5.  Risk Factors for Adverse Neurodevelopment in Transient or Persistent Congenital Hyperinsulinism.

Authors:  Marcia Roeper; Roschan Salimi Dafsari; Henrike Hoermann; Ertan Mayatepek; Sebastian Kummer; Thomas Meissner
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-30       Impact factor: 5.555

6.  A Novel Homozygous Mutation in the KCNJ11 Gene of a Neonate with Congenital Hyperinsulinism and Successful Management with Sirolimus.

Authors:  Sevim Ünal; Deniz Gönülal; Ahmet Uçaktürk; Betül Siyah Bilgin; Sarah E Flanagan; Fatih Gürbüz; Meltem Tayfun; Selin Elmaoğulları; Aslıhan Araslı; Fatma Demirel; Sian Ellard; Khalid Hussain
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-05-16

7.  Sirolimus-Induced Hepatitis in Two Patients with Hyperinsulinemic Hypoglycemia

Authors:  Belma Haliloğlu; Heybet Tüzün; Sarah E. Flanagan; Muhittin Çelik; Avni Kaya; Sian Ellard; Mehmet Nuri Özbek
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-12-08

8.  Activation of Protein Kinase A (PKA) signaling mitigates congenital hyperinsulinism associated hypoglycemia in the Sur1-/- mouse model.

Authors:  Mangala M Soundarapandian; Christine A Juliana; Jinghua Chai; Patrick A Haslett; Kevin Fitzgerald; Diva D De León
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

9.  Prevalence and safety of diazoxide in the neonatal intensive care unit.

Authors:  Keyaria D Gray; Kathryn Dudash; Carla Escobar; Colman Freel; Tylah Harrison; Chandler McMillan; Mihai Puia-Dumitrescu; C Michael Cotten; Robert Benjamin; Reese H Clark; Daniel K Benjamin; Rachel G Greenberg
Journal:  J Perinatol       Date:  2018-09-11       Impact factor: 3.225

10.  The danger of diazoxide in the neonatal intensive care unit.

Authors:  Jay Desai; Logan Key; Alyson Swindall; Kan Gaston; Ajay J Talati
Journal:  Ther Adv Drug Saf       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.